554 related articles for article (PubMed ID: 37719443)
1. Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions.
Ye J; Zheng L; He Y; Qi X
MedComm (2020); 2023 Oct; 4(5):e368. PubMed ID: 37719443
[TBL] [Abstract][Full Text] [Related]
2. Effect of Productive Human Papillomavirus 16 Infection on Global Gene Expression in Cervical Epithelium.
Kang SD; Chatterjee S; Alam S; Salzberg AC; Milici J; van der Burg SH; Meyers C
J Virol; 2018 Oct; 92(20):. PubMed ID: 30045992
[TBL] [Abstract][Full Text] [Related]
3. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
4. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
5. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.
Lee SJ; Yang A; Wu TC; Hung CF
J Gynecol Oncol; 2016 Sep; 27(5):e51. PubMed ID: 27329199
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
8. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
Liu SS; Tsang PC; Chan KY; Cheung AN; Chan KK; Leung RC; Ngan HY
Tumour Biol; 2008; 29(2):105-13. PubMed ID: 18515988
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia.
Temesgen MM; Alemu T; Shiferaw B; Legesse S; Zeru T; Haile M; Gelanew T
PLoS One; 2021; 16(3):e0248949. PubMed ID: 33760866
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of human papillomavirus vaccination in the prevention of recurrence of severe cervical lesions.
Sehnal Borek; Pichlík Tomáš; Halaška Michael J; Větrovská Monika; Babková Anna; Drozenová Jana; Robová Helena; Rob Lukáš
Ceska Gynekol; 2023; 88(4):294-300. PubMed ID: 37643912
[TBL] [Abstract][Full Text] [Related]
11. Current and future direction in treatment of HPV-related cervical disease.
Khairkhah N; Bolhassani A; Najafipour R
J Mol Med (Berl); 2022 Jun; 100(6):829-845. PubMed ID: 35478255
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
[TBL] [Abstract][Full Text] [Related]
13. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection.
Asiaf A; Ahmad ST; Mohammad SO; Zargar MA
Eur J Cancer Prev; 2014 May; 23(3):206-24. PubMed ID: 24129107
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus.
Corona Gutierrez CM; Tinoco A; Navarro T; Contreras ML; Cortes RR; Calzado P; Reyes L; Posternak R; Morosoli G; Verde ML; Rosales R
Hum Gene Ther; 2004 May; 15(5):421-31. PubMed ID: 15144573
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of high-risk HPV and its distribution in cervical precancerous lesions among 35-64 years old women who received cervical cancer screening in Beijing].
Shen J; Gao LL; Zhang Y; Han LL; Wang JD
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 May; 52(5):493-497. PubMed ID: 29747341
[No Abstract] [Full Text] [Related]
16. Risk Factors Associated With Human Papillomavirus Infection, Cervical Cancer, and Precancerous Lesions in Large-Scale Population Screening.
Yang D; Zhang J; Cui X; Ma J; Wang C; Piao H
Front Microbiol; 2022; 13():914516. PubMed ID: 35847094
[TBL] [Abstract][Full Text] [Related]
17. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.
Brinkman JA; Caffrey AS; Muderspach LI; Roman LD; Kast WM
Eur J Gynaecol Oncol; 2005; 26(2):129-42. PubMed ID: 15857016
[TBL] [Abstract][Full Text] [Related]
18. Burden of disease associated with cervical cancer in malaysia and potential costs and consequences of HPV vaccination.
Aljunid S; Zafar A; Saperi S; Amrizal M
Asian Pac J Cancer Prev; 2010; 11(6):1551-9. PubMed ID: 21338196
[TBL] [Abstract][Full Text] [Related]
19. Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China.
Zhao S; Zhao X; Hu S; Lu J; Duan X; Zhang X; Chen F; Zhao F
Chin J Cancer Res; 2019 Aug; 31(4):663-672. PubMed ID: 31564809
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of High-Risk HPV Subtypes and Efficacy of the HPV Vaccine in Preventing Cervical Epithelial Lesions: Survey and Insights from a German Study.
Abbas M; de Jonge J; Bettendorf O
Life (Basel); 2023 Jul; 13(8):. PubMed ID: 37629494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
